Semax
Boost cognitive performance, memory, and neuroprotection.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Semax
Semax is a synthetic heptapeptide analogue of ACTH(4-7) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It enhances BDNF expression, modulates serotonergic and dopaminergic systems, and provides neuroprotective effects. It is closely related to Selank but acts primarily through neurotrophic rather than anxiolytic pathways.
Key Benefits
- Enhances BDNF expression
- Modulates dopaminergic and serotonergic systems
- Provides neuroprotection against oxidative damage
- Complementary to Selank with different mechanism
Set a goal (top of the page) to see how Semax scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Mild nasal dryness
- Headache
- Dizziness
- Mild irritability at higher doses
Legal & Regulatory Status
Research use only in the US; approved as a nootropic in Russia and Ukraine. Human evidence is mostly small Russian-language studies with limited independent replication.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
- Efficacy of semax in patients at different stages of ischemic stroke (PMID 29798983)
- Semax in cerebrovascular insufficiency — clinical study (PMID 15792140)
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
